#Kedaara Capital

[kedaara]

Growth Oriented Investments Private Equity Funds in India - Kedaara Capital fund’s investment approach blends skilled investment judgment with extensive operating experience. Firm’s significant competitive advantages come through a disciplined investment approach coupled with ensuring full alignment with the entrepreneurs and management teams.

[hummingzone]

Purplle.com gets $75 million in funding from Kedaara, others

The fresh fund will accelerate the company’s goal to deliver six to eight times growth in the next five year Beauty e-commerce platform Purplle.com announced on Friday it has raised $75 million in a new financing round. Existing investors such as Sequoia Capital India and Blume Ventures have participated in the round, while the company has onboarded new investor Kedaara as well. The fresh fund…

[newsoutbursts]

Aavas Financiers gets board approval to raise Rs 100 cr via bonds New Delhi: Aavas Financiers on Tuesday said its board has approved plans to raise up to Rs 100 crore by issuing bonds on private placement basis.

[techminsolutions]

Purplle.com closes $140 mn Series D round adding Premji Invest to cap table

Purplle.com closes $140 mn Series D round adding Premji Invest to cap table

Online beauty platform Purplle.com has raised $65 million, bringing Premji Invest, the investment arm of Wipro billionaire Azim Premji, to the cap table. This investment comes weeks after a $75 million funding, led by Kedaara Capital, alongside Sequoia Capital India and Blume Ventures. The infusion will accelerate the company’s growth to build a multibillion-dollar company from India. The company…

[corpgv]

Norwest and Kedaara Capital lead a Rs500 crore round in MSME focused lender Veritas Finance

Norwest and Kedaara Capital lead a Rs500 crore round in MSME focused lender Veritas Finance

… with a high degree of corporate governance, technological prowess and institutionalization,… From:: Norwest and Kedaara Capital lead a Rs500 crore round in MSME focused lender Veritas Finance       

[kedaara]

Kedaara one of the Investment Management Companies has remained singularly dedicated to its stated strategy of focusing on investments built through trust based relationships with best-in-class entrepreneurs and management teams across secular fast growing end markets.

[salam2050]

Vijaya Diagnostic Center Has A Subdued Debut, Lists At 2% Premium On BSE and NSE

Vijaya Diagnostic Center Has A Subdued Debut, Lists At 2% Premium On BSE and NSE

At 10:10 am, Vijaya Diagnostic shares were trading higher by 8.8 per cent on BSE Vijaya Diagnostic Center’s shares made a subdued debut on the bourses. The shares of the Kedaara Capital-backed diagnostic chain listed at Rs 542.30 on the BSE, a premium of 2.13 per cent compared to the issue price of Rs 531 per share. On the NSE, the shares opened at Rs 540, a premium of 1.69 per cent. At 10:10…

[letsjanukhan]

UPDATE: Vijaya Diagnostic initial public offering (IPO) Opens For Subscription Today i.e. September 1 and will close on September 3

UPDATE: Vijaya Diagnostic initial public offering (IPO) Opens For Subscription Today i.e. September 1 and will close on September 3

<!– –> Vijaya Diagnostic Center shares are likely to be listed on September 14. Vijaya Diagnostic Center’s Rs 1,895.04 crore initial public offering (IPO) opens for subscription today i.e. September 1 and will close on September 3. The Kedaara Capital-backed diagnostic chain’s IPO is entirely an offer for sale of 35.69 million shares by existing shareholders. The shares will be sold in the…

[sidnazpro2020]

Latest News Today - Kedaara-backed Vijaya Diagnostic Files IPO Papers With

Latest News Today – Kedaara-backed Vijaya Diagnostic Files IPO Papers With

Vijaya Diagnostic is one of the largest diagnostic chains in southern India Vijaya Diagnostic, the diagnostic chain backed by private equity firm Kedaara Capital, has filed the draft red herring prospectus with the market regulator Sebi for its initial public offering (IPO). Vijaya Diagnostic is the second diagnostic chain to file for IPO this year, with Krsnaa Diagnostics having filed its…

[techminsolutions]

Beauty platform Purplle.com raises $75 mn from Kedaara, Sequoia and Blume

Beauty platform Purplle.com raises $75 mn from Kedaara, Sequoia and Blume

Purplle.com, one of India’s largest online beauty destinations, has raised $75 million funding round from investment firm Kedaara along with Sequoia Capital India and Blume Ventures. This comes six months after a $45 million funding backed by Verlinvest, Blume Ventures, JSW Ventures, and first-time investor Sequoia Capital India. The investment will augment the company’s goal to deliver 6-8x…

[psatalk]

Warburg in pole position to acquire control of Parksons Packaging – ET

American private equity firm Warburg Pincus is likely to have emerged as the highest bidder to acquire a controlling stake in Mumbai-based folding carton manufacturer Parksons Packaging. It is said Warburg Pincus outbid peers such as KKR and Bain Capital apart from the well established in India, global packaging major Huhtamäki Oyj, according to a report based on “multiple people aware of the deal” in the Economic Times.

Warburg’s potential deal will value the Mumbai-based packaging solutions company at Rs 2,200-2,300 crore, sources aware of the development told ET. The report indicates that the transaction will see the exit of private equity firm Kedaara Capital from the company founded by Ramesh Kejriwal in 1996.

Kedaara is said to have invested Rs 200 crore in the company in 2015 to buy about 25% stake that another private equity investor, ChrysCapital, held. The investment in Parksons Packaging will be Warburg’s fourth investment in India in the last six months if the deal goes through.

Kejriwal’s sons Siddharth and Chaitanya will continue to run the business and hold a minority stake post transaction, one of the sources told the financial daily. Parksons reported a revenue of Rs 946 crore during the fiscal year 2018-2019, while net profit stood at Rs 39.51 crore. According to ET, the company has not filed the numbers for the fiscal year 2019-2020 yet with the ministry of corporate affairs.

Parksons Packaging, headquartered in Mumbai, currently operates six monocarton packaging plants across five locations in India. In 2019, the company became the first in India to commission an HP Indigo 30000 digital press at its Daman plant. Daman is the first and oldest monocarton plant. Other plants are in Chakan near Pune, also in Western India, Pantnagar in North India, Sri City near Chenna in South India, and Guwahati in Northeast India.

Parksons Packaging operates a battery of offset Heidelberg, and KBA offset presses and modern converting and finishing equipment across its plants. Late last year, it commissioned a newly installed Rapida 76. It also became the first monocarton printer to commission the HP Indigo 30000, a B2-format (20 x 30-inch) in the country.

[kedaara]

Kedaara believes market leading businesses are built with a sound strategy, driven entrepreneurs, and commitment to operating excellence. The fund’s Private Equity Investment Activity approach blends skilled investment judgment with extensive operating experience. 

[salam2050]

Vijaya Diagnostic To Debut On The Bourses On Tuesday i.e. September 13

Vijaya Diagnostic To Debut On The Bourses On Tuesday i.e. September 13

Vijaya Diagnostic: The shares were sold in the price band of Rs 522-531 a share. Vijaya Diagnostic Center’s initial public offering (IPO) will list on the bourses tomorrow i.e. September 13. The Kedaara Capital-backed diagnostic chain’s was entirely an offer for sale of 35.69 million shares by existing shareholders and promoters, including Dr S Surenranath Reddy, Karakoram and Kedaara Capital…

[letsjanukhan]

UPDATE: Vijaya Diagnostic initial public offering (IPO) To Open On September 1

UPDATE: Vijaya Diagnostic initial public offering (IPO) To Open On September 1

<!– –> Vijaya Diagnostic Center’s Rs 1,895.04 crore initial public offering (IPO) will open tomorrow i.e. September 1. The Kedaara Capital-backed diagnostic chain’s IPO will entirely be an offer for sale of 35.69 million shares. The company has fixed the price band of the share offering at Rs 522 to Rs 531 a share. The share sale will close on September 3 and the shares are likely to be listed…

[planify]

Care Health Insurance IPO Review, Allotment Status, Subscription, Price, Date & More

Let’s have a detailed review of the company and analytics of the - Care Health Insurance IPO release date, IPO offer price, subscription- Care Health Insurance Pre IPO, Care Health Insurance unlisted shares, allotment, grey market price and other details like the company’s background, its financial positions, and its other related things.

 About Company

·       Care Health Insurance company Limited (renamed from Religare Health Insurance) was incorporated on July 2012 headquartered in Gurugram, Haryana.

•         It was the insurance arm of Religare Enterprise limited which is a specialized Health Insurer offering health insurance services to employees of corporates.

•         Care health Insurance is marketed by a team behind the hospital chain known as Fortis Health Care which is one of the six standalone health insurers in India.

•         The organization has been nominated the ‘Best Health Insurance company’ at ABP News-BFSI Awards & ‘claims service leader of the year.

•        In June 2020, Kedaara Capital Fund II LLP, acquired a further stake in Care Health for a total of₹567 Crores i.e. by primary capital infusion of ₹300Crores and purchasing 6.39% stake for a consideration of 267 Crores from existing shareholders. Stake increased to 72.02%.

Products and Services

1.       Health Insurance:

• Comprehensive family health insurance

• Diabetes Health insurance

• Heart disease insurance

• Senior Citizen insurance

• Arogya Sanjeevani insurance

• Cancer care

• Critical illness Mediclaim

2.       Travel insurance:

• International travel insurance

• International health and travel insurance for Students

3.       Corporate Insurance:

• Group Mediclaim insurance policy for employees

• Personal accident cover for employees with global coverage

• Group travel insurance for employees

  Industry Overview

·       The health insurance industry in India is the fastest growing segment in the non-life insurance sector. The market witnessed a robust double-digit growth of 24% in FY 17, with a market share of 24%, in the entire non-life insurance sector.

•         The health insurance industry is at an embryonic stage, with roughly 25% of the population under its coverage. There exists a huge potential for growth and penetration of health insurance to a larger population. Additionally, there are both opportunities and restraints in the marketing and distribution of health insurance products in India.

•         The launch of National Health Protection Scheme under Ayushman Bharat, in September 2018, in order to provide coverage of up to INR 500,000 (USD 7,723) to more than 100 million vulnerable families, holds heavy expectations, which increases penetration of health insurance in India, from nearly 34% to 50%.

•         Increasing awareness in the healthcare sector, owing to the growing healthcare costs and higher inflation in medical cost will be a potential driver in the growth of Health insurance industry.

•        With the advent of unforeseen pandemic (Covid-19), people are now more conscious about their health, which is influencing them to purchase medical insurance, renew their insurance or increase the sum assured of the medical insurance.

•         Book Care Health Insurance Unlisted shares from Planify.

 Strengths

 ·       Strong brand name with diversified products and services and providing almost all kind of Health Insurance.

•         The company has made significance progress in no time and is already operating out of 74 offices with employee strength of more than 2200 people with a network of 7800+ hospitals providing cashless medical services across the globe.

•         The Revenue from all operations have increased at a rate of 55.16% in the last 4 years.

•         Outstanding growth in operating profit, which witnessed a growth of 300% in last 4 years. • Gross written Premium has increased by more than 7 times in last 5 years.

•         Claim and settlement are super easy because of personal assistance and non-involvement of third party.

•       Products of the company is designed by keeping only one aspect in the mind and that is Convenience of the customers.

  Planify View

•         Rating – 4/5

•         Recommendation – Buy at current levels

•         Book Care Health Insurance shares from Planify.

•         Want to know about Care Health Insurance share price then contact Planify.

 Want to buy-   Care Health Insurance Pre IPO , Unlisted Shares, and De-Listed Shares? Come right to us!

Mail Us On — help@planify.in

Or Call Us On — (+91) 706–556–0002

[technowhk]

Kedaara Capital 選擇 SS&C 進行基金管理 http://dlvr.it/Rmy6X7